Manuela RODRIQUEZ Projects

1 Funded projects
The dramatic outcome of the Covid19 pandemic raised the necessity to have a general treatment to limit the evolution to severe infections. The interim result of the first vaccines showing an incomplete efficacy and the new virus variants left a therapeutic space for treatments based on different strategies. Monoclonal antibodies appear to have a promising effect, but because of their high cost the
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorRODRIQUEZ Manuela (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost13.342,37 euro
Project duration22 November 2021 - 22 November 2024

  Data source U-GOV dal 1 Gennaio 2013